Skip to content

Study · Non-randomized trial · 2004

4 results

Point injection of cerebrolysin in treatment of child cerebral palsy

Liang Xiaoming

Acta Academiae Medicinae Bengbu1 Jan 2004

PepBankPUB-93974208
Ask about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse.

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. 4 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In children with cerebral palsy, member function improved after Cerebrolysin point injection.

    In plain wordsIn children with cerebral palsy, limb function improved after Cerebrolysin point injection.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseMember function
    Study

    n: not reported in source

    Outcome group
    Exercise and physical function · Nervous system and cognition
    Studied dose
    Dose not stated · Tianzhu point injectionAs given in this study (human).

    Source sentences

    Summary
    The patients' member function,linguistic function and intelligence improved and the effective rate reached 81.3%.
    1 context sentence
    Summary · context
    From Oct.1994 to Oct.2002 child cerebral palsy was treated with Tianzhu point injection of cerebrolysin in our hospital.
  2. 02HumanNon-randomized trialEfficacy outcome

    In children with cerebral palsy, linguistic function improved after Cerebrolysin point injection.

    In plain wordsIn children with cerebral palsy, language function improved after Cerebrolysin point injection.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseLinguistic function
    Study

    n: not reported in source

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    Dose not stated · Tianzhu point injectionAs given in this study (human).

    Source sentences

    Summary
    The patients' member function,linguistic function and intelligence improved and the effective rate reached 81.3%.
    1 context sentence
    Summary · context
    From Oct.1994 to Oct.2002 child cerebral palsy was treated with Tianzhu point injection of cerebrolysin in our hospital.
  3. 03HumanNon-randomized trialEfficacy outcome

    In children with cerebral palsy, intelligence improved after Cerebrolysin point injection.

    In plain wordsIn children with cerebral palsy, intelligence improved after Cerebrolysin point injection.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseIntelligence
    Study

    n: not reported in source

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    Dose not stated · Tianzhu point injectionAs given in this study (human).

    Source sentences

    Summary
    The patients' member function,linguistic function and intelligence improved and the effective rate reached 81.3%.
    1 context sentence
    Summary · context
    From Oct.1994 to Oct.2002 child cerebral palsy was treated with Tianzhu point injection of cerebrolysin in our hospital.
  4. 04HumanNon-randomized trialEfficacy outcome

    In children with cerebral palsy, the reported effective rate after Cerebrolysin point injection reached 81.3%.

    In plain wordsIn children with cerebral palsy, the reported treatment response rate after Cerebrolysin point injection was 81.3%.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableEffective rate
    Study

    n: not reported in source

    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated · Tianzhu point injectionAs given in this study (human).

    Measurements

    Effective rate
    81.3%
    point injection

    Source sentences

    Summary
    The patients' member function,linguistic function and intelligence improved and the effective rate reached 81.3%.
    1 context sentence
    Summary · context
    From Oct.1994 to Oct.2002 child cerebral palsy was treated with Tianzhu point injection of cerebrolysin in our hospital.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.